<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">65614</article-id><article-id pub-id-type="doi">10.7554/eLife.65614</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>IL-33 promotes innate lymphoid cell-dependent IFN-γ production required for innate immunity to <italic>Toxoplasma gondii</italic></article-title></title-group><contrib-group><contrib contrib-type="author" id="author-221091"><name><surname>Clark</surname><given-names>Joseph T</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221038"><name><surname>Christian</surname><given-names>David A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221039"><name><surname>Gullicksrud</surname><given-names>Jodi A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221040"><name><surname>Perry</surname><given-names>Joseph A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221041"><name><surname>Park</surname><given-names>Jeongho</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221042"><name><surname>Jacquet</surname><given-names>Maxime</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221043"><name><surname>Tarrant</surname><given-names>James C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221044"><name><surname>Radaelli</surname><given-names>Enrico</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221045"><name><surname>Silver</surname><given-names>Jonathan</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-221046"><name><surname>Hunter</surname><given-names>Christopher A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3092-1428</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Pathobiology</institution>, <institution>University of Pennsylvania</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Veterinary Medicine and Veterinary Science</institution>, <institution>Kangwon National University</institution>, <addr-line><named-content content-type="city">Chuncheon</named-content></addr-line>, <country>Republic of Korea</country></aff><aff id="aff3"><institution content-type="dept">Liver Immunology</institution>, <institution>University Hospital of Basel and University of Basel</institution>, <addr-line><named-content content-type="city">Basel</named-content></addr-line>, <country>Switzerland</country></aff><aff id="aff4"><institution content-type="dept">Respiratory Infllammation and Autoimmunity</institution>, <institution>AstraZeneca</institution>, <addr-line><named-content content-type="city">Gaithersburg</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-18113"><name><surname>Belz</surname><given-names>Gabrielle T</given-names></name><role>Reviewing editor</role><aff><institution>The University of Queensland</institution>, <country>Australia</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>chunter@upenn.edu</email> (CH);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>30</day><month>04</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e65614</elocation-id><history><date date-type="received"><day>09</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>29</day><month>04</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Clark et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Clark et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-65614-v1.pdf"/><abstract><p>IL-33 is an alarmin required for resistance to the parasite <italic>Toxoplasma gondii</italic>, but its role in innate resistance to this organism is unclear. Infection with <italic>T. gondii</italic> promotes increased stromal cell expression of IL-33 and levels of parasite replication correlate with release of IL-33 in affected tissues. In response to infection, a subset of innate lymphoid cells (ILC) emerges composed of IL-33R<sup>+</sup> NK cells and ILC1s. In <italic>Rag1</italic><sup>-/-</sup> mice, where NK cells and ILC1 production of IFN-g mediates innate resistance to <italic>T. gondii</italic>, the loss of the IL-33R resulted in reduced ILC responses and increased parasite replication. Furthermore, administration of IL-33 to <italic>Rag1</italic><sup>-/-</sup> mice resulted in a marked decrease in parasite burden, increased production of IFN-g and the recruitment and expansion of inflammatory monocytes associated with parasite control. These protective effects of exogenous IL-33 were dependent on endogenous IL-12p40 and the ability of IL-33 to enhance ILC production of IFN-g. These results highlight that IL-33 synergizes with IL-12 to promote ILC-mediated resistance to <italic>T. gondii</italic>.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd><kwd>Other</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>5R01AI125563-05</award-id><principal-award-recipient><name><surname>Hunter</surname><given-names>Christopher A</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>5T32AI00753223</award-id><principal-award-recipient><name><surname>Hunter</surname><given-names>Christopher A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Jonathan Silver, Jonathan Silver is a full-time employee and shareholder of AstraZeneca..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#805045) of the University of Pennsylvania</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><supplementary-material><ext-link xlink:href="elife-65614-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>